Jynarque
Payments companies reported to CMS as associated with Jynarque. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Jynarque, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Jynarque
These are the largest totals companies reported as associated with Jynarque. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Danny Woo | Louisville, KY | Nephrology (Internal Medicine) | $174,709.69 |
| Jayakumar Vidhun | Whittier, CA | Nephrology (Internal Medicine) | $150,815.03 |
| Gerard Tepedino | Manhasset, NY | Nephrology (Internal Medicine) | $133,094.45 |
| Mohammed Ahmed | Bolingbrook, IL | Nephrology (Internal Medicine) | $114,689.74 |
| Osama Amro | Seattle, WA | Nephrology (Internal Medicine) | $108,748.15 |
| Luis Velez | San Antonio, TX | Nephrology (Internal Medicine) | $106,925.47 |
| Christopher Kwoh | Houston, TX | Nephrology (Internal Medicine) | $96,481.31 |
| Sreedhar Mandayam | Houston, TX | Nephrology (Internal Medicine) | $52,554.72 |
| John Foringer | Houston, TX | Nephrology (Internal Medicine) | $51,444.85 |
| Nelson Kopyt | Allentown, PA | Nephrology (Internal Medicine) | $51,035.68 |
Prescribed Jynarque?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.